INTRODUCTION
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions characterized by a dysregulated immune response that results in intestinal inflammation and tissue damage (Sartor, 2008; Khor et al., 2011) . Although there is a heritable component to IBD, genome-wide association studies fail to explain the majority of disease risk (Jostins et al., 2012) . This and the recent rapid increase in the prevalence of IBD suggest a major role for environmental factors in the etiology of IBD (Sartor, 2008) . The composition of the gut microbiota is increasingly appreciated as critical environmental factor with effects on numerous aspects of host physiology. IBD is associated with an altered intestinal microbiota (Frank et al., 2007; Gevers et al., 2014; Jacobs et al., 2016) and genetic defects in microbial handling are risk factors for the disease (Jostins et al., 2012) . Therefore, it is widely proposed that IBD occurs as the result of a dysregulated immune response to microbiota and individual susceptibility is determined by both host genetics and the composition of the gut microbiota (Sartor, 2008; Khor et al., 2011) .
Culture-independent analyses of the IBD microbiota reveal consistent characteristics that are associated with disease including reduced diversity and an increased ratio of Proteobacteria to Firmicutes compared to healthy individuals (Kostic et al., 2014) . However, as changes in the IBD microbiota may be shaped by the disease itself or after exposure to therapies, no definitive causal link has been made between human microbiota composition and IBD (Ni et al., 2017) .
Germ-free animals colonized with different microbiotas can be used to test causal relationships between microbiotas and host physiology while maintaining control over host genetics, diet, and environment (Ridaura et al., 2013; Blanton et al., 2016; Sampson et al., 2016; Cekanaviciute et al., 2017; Routy et al., 2018) . Such models show that gut microbiota plays a crucial role in shaping the immune system including microbiota-specific pro-and anti-inflammatory effects. Variation in microbiota composition consequently influences host susceptibility to models of autoimmunity, inflammatory disease, and infection both in gut and distant tissue sites (Ivanov et al., 2009; Atarashi et al., 2011 Atarashi et al., , 2017 Palm et al., 2014; Chudnovskiy et al., 2016; De Palma et al., 2017) . Germ-free mice have dramatically reduced lamina propria CD4 + T cells and colonization induces rapid expansion and differentiation of effector and regulatory T cell populations (Ö stman et al., 2006) . Colonization with different complex microbiotas or single immunomodulatory strains can induce varied responses and establish diverse gut immune landscapes (Ivanov et al., 2008; Atarashi et al., 2011; Geva-Zatorsky et al., 2017) . Among the cells most highly induced upon gut microbiota colonization in ex-germ-free mice are RORgt + FoxP3 À Th17 cells (Ivanov et al., 2008) and FoxP3 + regulatory T (Treg) cells (Atarashi et al., 2011; Geuking et al., 2011) . Th17 cells are found enriched in human IBD lesions, and microbiotas that strongly induce Th17 cells can exacerbate colitis in mouse models (Fujino et al., 2003; Chudnovskiy et al., 2016; Viladomiu et al., 2017) . The majority of gut Th17 cells are specific for microbial antigens (Yang et al., 2014; Tan et al., 2016) . Colonization of germ-free mice also increases the frequency of intestinal FoxP3 + Treg cells (Atarashi et al., 2011; Geuking et al., 2011) . Specialized subsets of lamina propria Treg cells are distinguished by expression of different transcription factors. GATA3 + Treg cells are particularly responsive to inflammation and have a transcriptional signature associated with tissue repair (Wohlfert et al., 2011; Schiering et al., 2014) . Approximately 30%-40% of colon FoxP3 + Treg cells express the transcription factor RORgt (Ohnmacht et al., 2015; Sefik et al., 2015) . RORgt + Treg cells are microbiota dependent, are enriched in gut tissue, and have a strongly suppressive and stable phenotype (Yang et al., 2016) . Mice with a selective deficiency of RORgt in Treg cells demonstrate that RORgt + Treg cells are required to maintain tolerance to microbiota and microbes that favor induction of RORgt + Treg cells can protect mice from colitis (Sefik et al., 2015) . These observations in mouse models support a hypothesis in humans whereby variation in microbiota composition alters the balance between effector and regulatory T cells (Omenetti and Pizarro 2015) , particularly Th17 and RORgt + Treg cells, contributing to the risk of developing intestinal inflammation. In mouse models of IBD, components of IBD-associated microbiotas can induce Th17-biased effector T cell responses and exacerbate disease severity (Hansen et al., 2010; Eun et al., 2014; Palm et al., 2014; Viladomiu et al., 2017) , and complete human fecal microbiotas from both healthy donors and donors with IBD can induce intestinal inflammation in susceptible mice (Moran et al., 2009; Rhee et al., 2009; Eun et al., 2014; Du et al., 2015; Natividad et al., 2015; Nagao-Kitamoto et al., 2016) . However, the scale of these studies has precluded identifying specific consequences of colonization with IBD microbiotas compared to healthy microbiotas and defining generalizable functional properties of IBD or healthy donor microbiotas.
Interventions targeting the microbiota are a potential path for IBD treatment. Recent clinical trials have demonstrated the potential of fecal microbiota transplantation (FMT) for treating individuals with ulcerative colitis (Moayyedi et al., 2015; Paramsothy et al., 2017) . FMT provides a benefit to approximately 25% of patients in these studies, but efforts to improve efficacy and refine this therapeutic approach are currently hampered by a poor understanding of the differences between gut microbiotas of the population of healthy individuals and individuals with IBD. A better understanding of the functional properties of healthy microbiotas relative to those from individuals with IBD may guide the stratification of patients, the design of more refined microbiotatargeted therapies, and the development of microbiota-focused biomarkers or diagnostics.
A population-scale understanding of the unique immunogenic features of healthy and disease microbiotas is needed to better understand how interpersonal variation in the gut microbiome influences disease risk and the functional biology of complex diseases, including IBD. Here we examined the impact of transferring the gut microbiotas of 32 healthy or IBD donors into ex-germ-free mice. Transfer of microbiotas from IBD donors drove distinct adaptive immune profiles in unchallenged mice, including greater induction of Th2 and RORgt + Th cells and reduced induction of RORgt + Treg cells relative to healthy donor microbiotas. IBD donor microbiotas also exacerbated disease in Rag1-deficient mice after transfer of naive CD4 + T cells. Our results demonstrate that IBD-associated microbiotas are consistently more pro-inflammatory than those from healthy donors, suggesting a unifying mechanism for the contribution of gut microbiota to IBD.
RESULTS

IBD and Healthy Donor Fecal Microbiotas Are Compositionally Similar
To gain an insight into unifying properties of IBD and healthy donor microbiotas, we characterized immune responses in mice colonized with more than 30 different human fecal microbiotas. This included both complete fecal microbiotas and cultured collections of microbes isolated from a donor fecal sample (Tables 1 and S1 ; Goodman et al., 2011; Faith et al., 2014) . To determine the microbial composition of these samples, we performed 16S rRNA gene amplicon sequencing of the donor fecal samples. Consistent with previous reports , an unweighted UniFrac analysis of the composition of the microbiotas did not distinguish between donors with IBD and healthy donors ( Figure 1A ). We also compared the composition of the cultured microbiota collections generated from healthy and donor microbiotas. Principle coordinates analysis using a Jaccard distance of species composition failed to discriminate between the cultured collections from healthy and IBD donors ( Figure 1B ). To determine the functional impact of these gut microbiotas on mucosal T cell populations, we colonized germ-free C57BL/6J (B6) mice with fecal slurries or pools of cultured fecal donor microbes (Goodman et al., 2011; Faith et al., 2014) from two independent cohorts of healthy donors (n = 15) or donors with IBD (n = 15; Table 1 ) (Jacobs et al., 2016; Contijoch et al., 2018) . Since IBD pathophysiology is associated with a dysregulated T cell response (Hegazy et al., 2017) , we focused on the gut CD4 + T cell compartment and performed a comprehensive measurement of CD4 + T helper (Th) and T regulatory (Treg) cells in the intestinal lamina propria of each colonized mouse using flow cytometry. Because of the established association of IBD with both Th17 cells and microbiota composition (Fujino et al., 2003; Yang et al., 2014; Omenetti and Pizarro, 2015) Figure 1D ; Ivanov et al., 2009 Figure 1F ).
Although the proportion of IFN-g + Th1, IL-22 + , and IL-17A + CD4 + T cells varied by donor microbiota ( Figure S1 ), these T cell subsets were not significantly altered in mice colonized with healthy microbiotas compared with IBD microbiotas (Figures 1G-1I studies (Faith et al., 2014; Geva-Zatorsky et al., 2017) , transfer of most microbiotas into gnotobiotic mice led to increased numbers of gut FoxP3 + cells as compared to baseline germfree levels (Figures 2A and 2B 
Transfer of Microbiotas from Healthy Donors Specifically Increases Numbers of RORgt + Treg Cells
The gut harbors subsets of Treg cells that have non-redundant functions, including those characterized by expression of RORgt and GATA3 (Wohlfert et al., 2011; Ohnmacht et al., 2015; Sefik et al., 2015; Yang et al., 2016; Xu et al., 2018) . We therefore used flow cytometry to examine the relative induction of Treg cell subsets by healthy and IBD donor microbiotas. Induction of RORgt + Treg cells in colon and ileum varied significantly with different microbiotas (p < 1 3 10 À15 , p < 1 3 10 À8 in colon and ileum, ANOVA; Figures 3A and 3B). In contrast to the total FoxP3 + Treg cell population, we observed a significant expansion of RORgt + Treg cells induced by healthy microbiotas relative to IBD microbiotas in both colon and ileum (p < 0.001, t test; Figure 3C ). This difference was significant across the two independent cohorts of microbiota donors ( Figure 3D) Figure S2D ). Colonization of gnotobiotic mice with healthy or IBD microbiotas increased the numbers of RORgt + Treg cells in mLN, with no significant difference observed between the two groups ( Figure 3E ). The proportion of RORgt + Treg cells in colon and ileum were correlated (p = 4 3 10
À5
, f-test), but neither correlated with the proportion in mLN ( Figure 3F ). This confirms previous observations that RORgt + Treg cells are a gut tissue-specific subset and suggests that the conditions required for RORgt + Treg cell differentiation are found uniquely in lamina propria (Ohnmacht et al., 2015; Sefik et al., 2015; Yang et al., 2016) . Colonic RORgt + Treg cells from mice colonized with either healthy or IBD microbiotas secreted minimal IL-17A when stimulated ex vivo compared to FoxP3
À
RORgt
+ Th cells ( Figure 3G ), as reported previously in SPF mice (Sefik et al., 2015 (Ohnmacht et al., 2015) . In the ileum of mice colonized with IBD microbiotas, there was a greater proportion of Helios + Treg cells relative to mice colonized with healthy donor microbiotas and, as expected (Sefik et al., 2015) , RORgt + Treg and Helios + Treg cells were inversely correlated ( Figure S2D) . A lower proportion of FoxP3 + CD4 + T cells expressed neither RORgt nor Helios (Figure S2 ). This ''double negative'' population was enriched in the colon mice colonized with IBD microbiotas relative to those colonized with healthy microbiotas ( Figure S2B ). As previous described (Ohnmacht et al., 2015) , the proportion of FoxP3 + GATA3 + Treg cells was not significantly increased in colonized mice relative to germ-free mice, and they were not differentially modulated by healthy and IBD microbiotas ( Figure S2C ). These data, and the inverse correlation of RORgt + Treg with GATA3 + and Helios + Treg cells ( Figure S2D It has been suggested that RORgt + Treg cells are uniquely positioned to regulate Th2 cell responses (Ohnmacht et al., 2015) . Although we observed a significant expansion of Th2 (GATA3 +
FoxP3
À CD4 + ) cells in the colon of gnotobiotic mice colonized with IBD microbiotas relative to healthy microbiotas (p < 0.05, t test; Figures 1J and 1K) , the proportion of Th2 cells was uncorrelated with RORgt + Treg cells (p = 0.09, p = 0.9 in colon and ileum; Figure S3A ). We also found no correlation be- Figure S3B ).
IBD-Associated Microbiotas Transmit Enhanced Colitis Severity to Susceptible Mice
To assess whether IBD-associated microbiotas influence colitogenesis, we tested healthy-and IBD-donor microbiotas in a gnotobiotic mouse model of colitis. Given the known importance of T cells in IBD pathophysiology, we chose a model of colitis that is dependent on both T cells and microbiota. Transfer of CD45RB hi (naive) CD4 + T cells to Rag1-deficient mice induces colitis-like pathology, but only in the presence of an immunogenic microbiota (hereafter the Rag T cell transfer [RagTCT] model) (Powrie et al., 1993; Stepankova et al., 2007) . At 4-8 weeks prior to T cell transfer, we colonized germ-free Rag1 À/À mice with fecal microbiotas from both healthy (n = 16) or IBD (n = 14) human donors (see Table 1 ). The alpha diversity (Shannon) of microbiota from B6 and Rag À/À colonized with the same human donor microbiota were significantly correlated (r 2 = 0.6, p = 0.002, f-test), an indication of similar engraftment between the mouse models. A control microbiota included in every iteration of the colitis model demonstrated low inter-experiment variation (Figure S4A) . As measured by loss in body mass, histology, and elevation of fecal lipocalin2 (LCN2), colitis was more severe in mice colonized with fecal microbiotas from individuals with IBD than those colonized with microbiotas from healthy donors (p = 4.2 3 10 À5 , p = 0.0058 6 weeks after T cell transfer for body mass and LCN2, respectively, t test; Figures 4A and 4B ). Loss in body mass was correlated with elevated fecal LCN2 (R 2 = 0.33, p = 1.4 3 10 À7 ; Figure S4B ). Remarkably, a significant difference in weight loss between healthy and IBD microbiotas was already detectable 7 days after T cell transfer and became more prominent over time ( Figure S4C ). There was no significant difference in colitis severity between mice colonized with microbiotas from donors with UC compared to CD (p = 0.59, t test; Figure 4D) , and CD and UC microbiotas each independently induced colitis that was more severe than in mice colonized with healthy donor microbiotas (p < 0.01, p < 0.001 for UC and CD, respectively, ANOVA; Figure 4D ). We replicated these findings in two independent cohorts of donors ( Figures 4E and S4D ). We also found both stool microbiotas and cultured collections of microbes from donors with IBD were similarly able to increase colitis susceptibility in mice, relative to healthy donor microbiotas (Figures 4F and S4E ). Colitis was not significantly different in mice colonized with IBD microbiotas from donors with active disease or in remission ( Figure S4F ). For ten donors, we assayed the colitogenicity of both the stool and the cultured microbiota collection derived from the stool. Eight of the ten cultured microbiotas transferred colitis of equivalent severity as the total stool microbiota derived from the same donor ( Figure S4G ). We considered that induction of intestinal inflammation could alter the composition of the microbiota and that outgrowth of pathogenic strains could contribute to colitis progression. We performed 16S rRNA amplicon sequencing on feces from the RagTCT mice both before colitis induction and 6 weeks after T cell transfer, around the peak of disease for susceptible mice. We observed no difference in the alpha diversity of the engrafted healthy or IBD microbiotas, either before or after colitis induction ( Figure 4G ). There were also no consistent changes in the broad taxonomic composition of the fecal microbiotas of the RagTCT mice after colitis induction ( Figure 4H ).
Within groups of mice colonized with one of five healthy or six IBD microbiotas, we characterized the activation and differentiation of the progeny of the transferred CD45RB HI T cells 4 weeks after transfer. Interpretation of immune population variation between these groups is complicated by the microbiota-induced variation in disease severity 4 weeks post-transfer. It was previously demonstrated that exacerbation of colitis in mice is associated with an increased proportion of IFN-g + IL-17A + CD4 + T cells (Ahern et al., 2010) . In line with these observations, we find the same population expanded in T cell transfer mice colonized with the IBD microbiotas ( Figure 4I ). We also found an increased proportion of RORgt + Th (FoxP3 À ) cells in the colon of these mice ( Figure 4J ). As previously reported (Uhlig et al., 2006) , between 1% and 2% of the expanded cells in lamina propria expressed FoxP3 ( Figures 4J and 4K ). This proportion was not significantly different between mice colonized with healthy or IBD microbiotas ( Figures 4J and 4K ). It was notable that an average of 40%-50% of the FoxP3 + cells co-expressed RORgt, indicating that the splenic origin of the naive T cells did not hamper RORgt + Treg cell development ( Figures 4J and   4K ). However, the proportion of RORgt + Treg cells was highly variable between animals and there was no significant difference in the proportion of RORgt + Treg cells between mice colonized with healthy or IBD microbiotas ( Figure 4K ). induced by a microbiota in B6 mice was positively correlated with colitis severity in RagTCT mice colonized with the same microbiota (R 2 = 0.32, p = 0.001; R 2 = 0.26, p = 0.004 for colon and ileum, respectively; Figure 5A ). Induction of RORgt + Treg cells in B6 mice was inversely correlated with colitis severity in RagTCT mice (R 2 = 0.29, p = 0.002; R 2 = 024, p = 0.006 for colon and ileum, respectively; Figure 5A ). The proportion of IL-17A + CD4 + T cells induced in colon was also weakly associated with colitis severity (R 2 = 0.25, p = 0.013; Figure S5 ). A linear model explained 53% of the variation in colitis severity (weight loss at week 6) as a function of the proportion of both RORgt + Th and RORgt + Treg cells in both tissues (R 2 = 0.53, p = 0.002; F-test).
Colitis severity was not associated with Helios + Treg, IL-10 + , or IFN-g + CD4 + T cells ( Figure S5 ). We used receiver operating characteristic (ROC) curves to assess the value of the humanized-microbiota mouse data in predicting the health status of the human microbiota donor using a logistic model ( Figure 5B ). The proportion of colon RORgt + Th cells had reasonable predictive value (AUC = 0.71), but the proportion of colon RORgt + Treg cells was more informative (AUC = 0.92) ( Figure 5B ). Colitis severity as measured by weight loss 6 weeks after T cell transfer was also highly predictive of donor health (AUC = 0.93) ( Figure 5B ). We found the best predictive power when the proportion of colon RORgt + Treg cells induced under homeostatic conditions and colitis severity at week 6 in RagTCT mice were combined in the logistic model (AUC = 0.95) ( Figure 5B ).
DISCUSSION
By colonizing germ-free mice with fecal microbiotas from more than 30 human donors, we demonstrated that there are consistently altered immune responses induced by human gut microbiotas from donors with IBD relative to healthy donors. Specifically, mice colonized with IBD microbiotas had a greater number of gut Th17 cells and fewer gut RORgt + Treg cells than mice colonized with healthy donor microbiotas. In a T cell transfer model of colitis, mice colonized with IBD microbiotas experienced more severe disease than those colonized with healthy donor microbiotas. Culture-independent analyses of the composition of the gut microbiota in individuals with IBD, together with animal models and genetic risk factors, have led to a widely held belief that the gut microbiota plays a role in the development and progression of the disease in genetically susceptible individuals. Through the data presented here, we provide further evidence that supports this hypothesis.
Genetic association studies implicate Th17 cells in IBD, and these cells are enriched in tissue of individuals with IBD (Fujino et al., 2003; Jostins et al., 2012) . In small clinical studies, RORgt + Treg cells are described in several human tissues (Voo et al., 2009 ), but both RORgt + FoxP3 + and IL-17 + FoxP3 + cells are particularly abundant in gut (Hovhannisyan et al., 2011; Han et al., 2014; Sefik et al., 2015) . No specific correlation between RORgt + Treg cells and IBD has been made, but our observations in this manuscript suggest that a well-powered clinical study is warranted to assess the role microbiota-induced RORgt + Treg cells may play in the pathobiology of IBD. The mechanisms that drive divergent induction of Th17 cells or RORgt + Treg cells in mice colonized with different microbiotas are unclear. These cell populations share many common features, including a requirement for IL-6, IL-23, and Stat3 signaling (Ohnmacht et al., 2015) . It is therefore intriguing to consider what might drive induction of one subset over the other. Dietary retinoic acid (RA) can boost RORgt + Treg cell induction (Ohnmacht et al., 2015) but can also modulate microbiota composition, making it hard to determine direct verses indirect effects (Cha et al., 2010) . Th17 cells can be induced in gut tissue after adhesion of microbes to the epithelium Sano et al., 2015) . This is particularly notable as adhesive/invasive strains of E. coli (AIEC) have been found enriched in the mucosa of individuals with IBD (Darfeuille-Michaud et al., 2004) and at least some AIEC are able to induce Th17 cells (Viladomiu et al., 2017) . The Th17 cell-inducing microbiotas identified in this study may harbor strains that induce Th17 cells through adhesion to the epithelium. Further studies are clearly warranted to determine the mechanisms by which healthy and IBD microbiotas alter the immune landscape in the gut. In mice colonized with IBD microbiotas, we also observed significantly more GATA3 + Th2 cells as compared to mice colonized with healthy donor microbiotas. Although Th2 cell-biased immune responses are typically associated with intestinal homeostasis and tissue repair (Allen and Sutherland 2014) , elevated Th2 cytokines have been observed in mucosal tissue from individuals with ulcerative colitis, and certain haptan-induced mouse models of colitis are Th2 cell dependent (Heller et al., 2002) . Th2 cells may be specifically sensitive to regulation by RORgt + Treg cells (Ohnmacht et al., 2015) . (Ohnmacht et al., 2015; Sefik et al., 2015) , under conditions where this population is deficient, it is possible that the RORgt À Treg cell populations compensate to maintain homeostasis. There may be a specific role for gut GATA3 + Treg cells during inflammation (Wohlfert et al., 2011) , and an analysis of the induction and function of these cells in colitic animals is warranted. Although we found that an increased proportion of RORgt + Treg cells correlated with reduced DC activation, we did not find a correlation of RORgt + Treg cells with any specific T helper cell subset that is generalizable across all microbiotas that could explain how RORgt + Treg cells may protect from colitis. In SPF conditions, mice lacking RORgt + Treg cells show a specific expansion of Th2 cells in one study (Ohnmacht et al., 2015) and expanded Th1 and Th17 cells in another (Sefik et al., 2015) , demonstrating the varied roles RORgt + Treg cells may play in regulating T cell responses.
Tracking genetic and environmental differences between populations with and without disease has been an essential scientific paradigm to attribute individual traits or exposures to a disease. Numerous population-scale host genetics initiatives have led to the identification of genetic variants that explain 18%-26% of IBD susceptibility risk (Jostins et al., 2012; Liu et al., 2015) -a critical advance in our knowledge of IBD that still leaves the majority of risk unexplained. Across two cohorts of individuals, we describe immunomodulatory capabilities that are found extensively and specifically in the gut microbiota of individuals with IBD compared to healthy control subjects. Thus, we can ascribe a critical role for microbiome in the etiology of IBD and provide an immunological basis underlying this inference. Furthermore, it offers a mechanistic hypothesis explaining gut microbiota as a risk factor for IBD, whereby individuals harboring communities that enrich tolerogenic RORgt + Treg cells are at reduced risk, while those harboring communities that enrich Th17 cells are at increased risk. The lack of differences between healthy and IBD donor gut microbiome composition and diversity suggest that the functional impact of the microbiota lies in the strain-level composition of each unique community or in the unique combination of strains in each individual. The consistency in data from mice colonized with cultured and complete microbiotas from donors with IBD provide the prospect of determining the relative contribution of individual isolated strains to specific host phenotypes (Faith et al., 2014) . Finally, these data further support the microbiota as a viable target for therapeutic intervention in IBD and provide a hypothesis for rational design of microbiota-directed preventative strategies and treatment in IBD.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Detail of the human microbiota donors can be found in Table 1 . All fecal samples were obtained from a stool biobank from two prior IRB approved clinical studies (Jacobs et al., 2016 . All subjects were given a study identification number that all their study samples were labeled with. All study samples were processed with no identifiers linked to them other than their study ID. Germ free C57BL/6J and Rag1-deficient C57BL/6J (B6.129S7-Rag1tm1Mom/J) mice were bred in-house at the Mount Sinai Immunology Institute Gnotobiotic Facility. Mice were colonized at 4-6 weeks old and flow cytometry analysis or T cell transfer was performed 8-12 weeks old. In total, 74 female and 79 male gnotobiotic C57BL/6 mice and 120 female and 147 male Rag1À/À mice were used in this study. Specific pathogen free C57BL/6J mice from Jackson Labs were used as T cell donors at 8-10 weeks old. All phenotyping experiments in B6 mice included both male and female mice. Of the 30 microbiotas screened in the Rag1-deficient colitis model, 26 were tested in both male and female mice. All mouse experiments were approved by the Mount Sinai Institutional Animal Care and Use Committee.
METHOD DETAILS
Human samples and bacterial culture Human stool samples from were frozen at À80 C before processing. Samples were pulverized under liquid nitrogen. Under strict anaerobic conditions $500mg of pulverized stool from each donor was blended into a slurry (40-50mg/mL) in pre-reduced bacterial culture media (LYBHIv4 media (Sokol et al., 2008) ; 37 g/l Brain Heart Infusion [BD], 5g/l yeast extract [BD] , 1 g/l each of D-xylose, D-fructose, D-glactose, cellubiose, maltose, sucrose, 0.5 g/l N-acetylglucosamine, 0.5 g/l L-arabinose, 0.5 g/l L-cysteine, 1g/l malic acid, 2 g/l sodium sulfate, 0.05% Tween 80, 20 mg/mL menadione, 5 mg/l hemin (as histidine-hemitin), 0.1 M MOPS, pH 7.2). The slurries were passed through sterile 100 mm strainers to remove large debris. To store for later administration to mice, slurries were diluted 1:20 in LYBHIv4 media containing 15% glycerol (final concentration) and stored at À80 C. Arrayed culture collections were generated for selected donors as previously described. Briefly, clarified and diluted donor stool was plated onto a variety of solid selective and non-selective media under anaerobic, micro-aerophilic and aerobic conditions. Plates were incubated for 48-72 hours at 37 C. 384 single colonies from each donor microbiota were individually picked and regrown in liquid LYBHIv4 media for 48 hours under anaerobic conditions. Regrown isolates were identified at the species level using a combination of MALDI-TOF mass spectrometry (Bruker Biotyper) and 16S rDNA amplicon sequencing. An average of 16 unique species were isolated from each fecal sample (range 10-29; Supplemental Data Table 1 ). There was no significant difference in the number of unique isolates obtained from healthy donor and IBD donors (p = 0.19, Mann-Whitney). All regrown isolates were stored in LYBHIv4 with 15% glycerol at À80 C as a pooled cocktail for administration to mice.
Gnotobiotic mice
Germ free C57BL/6J and C57BL/6J Rag1-deficient (B6.129S7-Rag1 tm1Mom /J) mice were bred in-house at the Mount Sinai Immunology Institute Gnotobiotic Facility in flexible vinyl isolators. To facilitate high-throughput studies in gnotobiotic mice we utilized ''out-of-the-isolator'' gnotobiotic techniques (Faith et al., 2014) . Shortly after weaning (28-42 days old) and under strict aseptic conditions, germ-free mice were transferred to autoclaved filter-top cages outside the of the breeding isolator and colonized with human microbiotas; Mice were colonized with 200-300 mL of a fecal slurry or pooled cocktail of cultured strains by oral gavage, given only once. Alternatively, mice were colonized with a mouse specific pathogen free microbiota, with or without segmented filamentous bacteria, from the cecal contents of C57BL/6J or C57BL/6NTac mice from Jackson Labs or Taconic farms respectively. All experiments were performed at least 28 days after colonization.
16S rDNA sequencing and analysis
The composition of human fecal samples was analyzed by 16S rRNA gene amplicon sequencing as previously described , Reyes et al., 2013 and in Contijoch et al. BioRxiv, 2018 . DNA was extracted by bead-beating followed by QiaQuick columns (QIAGEN) and quantified by Qubit assay (Life Technologies). The V4 region of the 16S gene was amplified by PCR and paired-end 250bp reads sequenced on an Ilumina MiSeq. Analysis was performed with MacQIIME 1.9.1.8 (Caporaso et al., 2010) and using open source R packages. OTUs were picked with 97% sequence similarity. OTUs were aligned to the Greengenes reference set, requiring 150bp minimum sequence length and 75% ID.
Lymphocyte isolation
Spleen and mesenteric lymph nodes were collected into RPMI containing 5% fetal bovine serum (FBS). Single cell suspensions were obtained by pressing though 40 mm strainers. Red blood cells were removed with ACK Lysing Buffer (GIBCO). Gut tissues were separated, opened longitudinally and washed in Hanks Buffered salt solution (HBSS) to remove intestinal contents. Ileum was defined as the distal 1/3 of the small intestine. Peyers patches were removed. Epithelial cells were removed by gentle shaking in HBSS (Ca/Mg free) with 5 mM EDTA, 15 mM HEPEs and 5% FBS for 30 min. The remaining tissue was washed in HBSS before mincing with scissors into digestion buffer (HBSS, 2% FBS, 0.4mg/mL Collagenase Type IV [Sigma Aldrich C5138], 0.1-0.25 mg/mL DNase1 [Sigma Aldrich DN25] ) and incubated at 37 C with gentle shaking for 30-40 min. The resulting suspensions were passed sequentially though 100 mm and 40 mm strainers. No gradient centrifugation enrichment of lymphocytes was performed, except for in preparation of the data in Figures S2E and S2G where mononuclear lymphocytes were enriched in a discontinuous gradient of 40%-80% Percoll.
Flow cytometry
For analysis of intracellular T cell cytokines (IL-10, IFNg, IL-17A, IL-22), lamina propria lymphocytes were restimulated in complete RPMI with 5 ng/mL phorbal 12-myristate 13-acetate (PMA) and 500 ng/mL ionomycin in the presence of monensin (Biolegend) for 3.5 hours at 37 C. For analysis of intracellular ILC cytokines, lamina propria lymphocytes were incubated at 37 C for 4 hours with 5 mg/mL Brefeldin A (Biolegend) without additional restimulation. Dead cells were excluded from all analyses using Zombie Aqua Fixable Viability dye (Biolegend). For intracellular cytokine staining, cells were fixed with IC Fixation Buffer (eBioscience) and transcription factors were detected in unstimulated cells fixed with FoxP3 Fixation/Permeabilization buffers (eBioscience). Simultaneous detection of cytokines and transcription factors was achieved by sequential staining; first of cytokines using IC Fixation buffer followed by transcription factors in Fixation/Permeabilization buffers. All data was acquired on the same LSRII instrument (BD Biosciences), with the exception of the data in Figure S3B that was acquired on a FACSAriaII (BD Biosciences), and analyzed using FlowJoX (TreeStar).
T cell transfer colitis T cell transfer colitis experiments were performed as previously described . Briefly, naive (CD45RB HI , CD25 -) CD4 T cells were isolated from the spleen and subcutaneous lymphnodes of 7-9 week old specific pathogen free C57BL/6J mice (The Jackson Laboratory). Following tissue dissociation and red blood cell lysis CD4 + T cells were enriched using negative magnetic selection (Magnisort, eBioscience). The resulting cells were stained for expression of CD4, CD25 and CD45RB. A fraction representing $50% of the total CD4 + population, selected on the basis of absent CD25 staining and high CD45RB staining was sorted using a FACSAria (BD Biosciences). Purity of the sorted fraction was checked and routinely exceeded 98%. Sorted cells were washed multiple times with sterile PBS. Rag1 À/À mice received 1x10 6 CD45RB HI T cells in 200 mL of sterile PBS by intraperitoneal injection. Donor cells were sex-matched to recipients. Mice colonized with healthy and IBD donor microbiotas had no significant difference in initial body mass before T cell transfer (22.36 ± 3.8 versus 22.95 ± 3.8 g, p = 0.2; t test).
Mice were weighed and fecal pellets were collected at the time of T cell transfer and weekly thereafter. Any mouse experiencing > 80% loss in body weight or which was deemed otherwise moribund was euthanized. In these cases, the last measurements of body mass or LCN2 taken for that mouse were carried forward and included in the data for subsequent time points. Inter-experimental variation was assessed across the screen by including one cultured donor microbiota in each experiment. This donor (UC1024) induced highly reproducible colitis in many repeats over $2 years ( Figure S4A ). We set pre-determined exclusion criteria for any experiment where mice colonized with UC1024 did not develop colitis in this reproducible manner.
Histology
Histology was performed by HistoWiz Inc (https://home.histowiz.com). Tissue was fixed in 10% buffered formalin, embedded in paraffin and 4 mm sections were cut before staining with hematoxylin and eosin. Slides were scanned with an Aperio AT2 (Leica).
LCN2 measurements
Lipocalin2 concentrations were measured in feces as a biomarker of intestinal inflammation (Chassaing et al., 2012) . Fecal pellets were collected into sterile pre-weighed and barcoded tubes and frozen at À20 C until the time of analysis. Pellets were weighed and suspended in 500 mL of sterile PBS by shaking in a BeadBeater (with no beads in the tube) for 2 min. Tubes were centrifuged at 4000rpm for 20 min. The resulting supernatant was assayed for LCN2 by sandwich ELISA (R&D systems). The concentration of LCN2 was normalized to the weight of the input feces.
DATA AND SOFTWARE AVAILABILITY
16S rDNA datasets analyzed in the manuscript are available through NCBI under accession numbers PRJNA436992 and PRJNA413199. Specific BioSample accession numbers are listed in Table 1. 
